Treatment with colchicine and survival of patients with ascitic cirrhosis: A double-blind randomized trial

Panminerva Medica

Volumn 40, Issue 1, 1998, Pages 75-81

  Adhami, J E ^a,b   Basho, J ^a  

^a University Medical Center of Tirana   (Albania)

^b Rruga Bardhok Biba   (Albania)

Author keywords

Ascites drug therapy; Colchicine, therapeutic use; Liver cirrhosis; Survival analysis

Indexed keywords

COLCHICINE; DIURETIC AGENT;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADULT; AGED; ASCITES; COLCHICINE; DIURETICS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0032018118     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Rojkind M, Uribe M, Kershenobich D. Coichicine and the treatment in liver cirrhosis. Lancet 1973;I:38-9.
2. Kershenobich D, Uribe M, Suarez GI, Mata JM, Perez-Tamayo R, Rojkind M. Treatment of cirrhosis with colchicine. A double-blind randomized trial. Gastroenterology 1979;77:532-6.
3. Adhami JE, Resuli B Mjekimi i cirrozave te melcise me kolkicine. Buletini i Shk Mjek 1982;22(4):23-34.
4. Adhami JE, Resuli B, Bodinaku K, Basho J Survie des cirrhotiques traites par colchicine Med Chir Dig Paris 1991;20(4):211-3.
5. Robert M, Pertman B. Influence des diuretiques sur la survie de 180 malades porteurs d'une cirrhose hepatique avec ascite Shweiz Med Wschr 1969;99:178-82.
6. Rojkind M, Mourelle M, Kershenobich D Anti-inflammatory and antifibrogenic activities of colchicine: Treatment of Liver cirrhosis. In: Liss AR, editor. Myelofibrosis and the Biology of Connective Tissue. New York 1984:475-89.
7. Rojkind M, Kershenobich D. Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices. Biochem Biophys Acta 1975;378:415-23.
8. Adhami JE. Perdonmi i kolkicines ne cirrozat hepatike eksperimentale. Rev Mjek 1984;4-5:42-6.
9. Kershenobich D, Vargas F, Garcia-Ta-Tsao G, Ferez Tamayo RH, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988;318:1709-13.
10. Warnes ThW, Smith A, Lee FI, Haboubi NY, Johnson Ph J, Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol 1987;5:1-7.
11. Christensen E, Schlighting P, Kragh Andersen P, Faueholdt L. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox' s multiple regression model for time-dependent variables. Scand J Gastroenterol 1986;21:174-6.
12. Adler M, Van Laethem J, Gilbert A, Gelin M, Bourgeois N, Vereerstraeten P et al. Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis. Dig Dis Sci 1990;35:1-5.